Powerful Medical
Powerful Medical is at the forefront of AI-driven cardiovascular diagnostics, aiming to reduce deaths caused by cardiovascular diseases. Their flagship product, PMcardio, is an AI-powered platform that interprets ECGs in seconds, detecting over 40 ECG conditions, including STEMI and reduced Left Ventricular Ejection Fraction. The platform is trusted by over 100,000 healthcare professionals and has been clinically validated in over 15 independent studies, demonstrating superior sensitivity and accuracy compared to standard methods. PMcardio is available for both individuals and organizations, with features like AI explainability heatmaps, comprehensive diagnosis coverage, and seamless integration into clinical systems. The company emphasizes data-driven decisions, rigorous clinical validation, and a commitment to transforming cardiac patient care.
Powerful Medical
Powerful Medical is at the forefront of AI-driven cardiovascular diagnostics, aiming to reduce deaths caused by cardiovascular diseases. Their flagship product, PMcardio, is an AI-powered platform that interprets ECGs in seconds, detecting over 40 ECG conditions, including STEMI and reduced Left Ventricular Ejection Fraction. The platform is trusted by over 100,000 healthcare professionals and has been clinically validated in over 15 independent studies, demonstrating superior sensitivity and accuracy compared to standard methods. PMcardio is available for both individuals and organizations, with features like AI explainability heatmaps, comprehensive diagnosis coverage, and seamless integration into clinical systems. The company emphasizes data-driven decisions, rigorous clinical validation, and a commitment to transforming cardiac patient care.
TL;DR
Product: PMcardio — AI ECG interpretation detecting 30–40+ conditions (including STEMI/OMI and AF)
Regulatory status: CE-marked as EU MDR Class IIb medical device (platform modules vary by region)
scale: Trusted by 100,000+ healthcare professionals; deployed in hospitals across European markets
Clinical validation: Peer-reviewed validation in 15+ independent studies
Recent funding: Received EIC funding (€7.5M package) and announced seed round (€6.2M) among other grants/rounds
Company Overview
Problem Domain
Cardiovascular diagnostics; rapid ECG interpretation to detect acute and chronic cardiac conditions.
Industry
Medtech / Digital Health
Funding Track Record
€6.2M
€7.5M (€2.5M grant + €5M follow-on investment)
Reported as a grant round on Jul 28, 2025
Investor Signal
“Venture To Future Fund, CB ESPRI Impact One, bpd partners, Life Extension Ventures, Zero Gravity Capital and public EIC/European Commission support”